
- NSCLC (Issue 8)
- Volume 8
- Issue 3
SBRT in Surgery for Patients With Early NSCLC
Roy Decker, MD, PhD, associate professor of therapeutic radiology, assistant professor of surgery (Otolaryngology), Clinical Research Program Leader, Therapeutic Radiology, Yale University, discusses stereotactic body radiation therapy (SBRT) in surgery for patients with early non-small cell lung cancer (NSCLC).
Decker explains how SBRT is highly accurate when delivering high doses of radiation to small lung tumors. Typically, it is delivered in three or five treatments or fractions. Results are very similar to that of surgery, and it has become acceptable to give this type of therapy to those who may be at high-risk for surgery.
Roy Decker, MD, PhD, associate professor of therapeutic radiology, assistant professor of surgery (Otolaryngology), Clinical Research Program Leader, Therapeutic Radiology, Yale University, discusses stereotactic body radiation therapy (SBRT) in surgery for patients with early non-small cell lung cancer (NSCLC).
Articles in this issue
almost 11 years ago
Radiation Therapy Dose for the Treatment of Patients With Lung Canceralmost 11 years ago
Combinations of Checkpoint Inhibitors Under Investigation in NSCLCalmost 11 years ago
EGFR Mutations in Patients With Lung Canceralmost 11 years ago
Next-Generation Agents in Development for NSCLCalmost 11 years ago
Clinical Trials in EGFR-Mutant NSCLC Hasten Precision Medicine Initiativesalmost 11 years ago
Immunotherapy Versus Targeted Therapy - Which Has Greater Impact in NSCLC?almost 11 years ago
Remarkable Six Months for Treatment Options in NSCLC


























